Identification of novel susceptibility methylation loci for pancreatic cancer in a two-phase epigenome-wide association study

References

• Henley SJ, Ward, EM, Scott, S, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126(10):2225–2249.
   Google Scholar
• Amundadottir L, Kraft, P, Stolzenberg-Solomon, RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986–990.
   Google Scholar
• Petersen GM, Amundadottir, L, Fuchs, CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42(3):224–228.
   Google Scholar
• Wolpin BM, Rizzato, C, Kraft, P, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014;46(9):994–1000.
   Google Scholar
• Tang H, Wei, P, Duell, EJ, et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014;35(5):1039–1045.
   Google Scholar
• Tang H, Wei, P, Duell, EJ, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(1):98–106.
   Google Scholar
• Childs EJ, Mocci, E, Campa, D, et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 2015;47(8):911–916.
   Google Scholar
• Klein AP, Wolpin , BM, Risch, HA, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun. 2018;9(1):556.
   Google Scholar
• Tang HW, Jiang, L, Stolzenberg-Solomon, RZ, et al. Genome-wide gene-diabetes and gene-obesity interaction scan in 8,255 cases and 11,900 controls from panscan and PanC4 consortia. Cancer Epidemiol Biomarkers Prev. 2020;29(9):1784–1791.
   Google Scholar
• van Dongen J, Nivard, MG, Willemsen, G, et al. Genetic and environmental influences interact with age and sex in shaping the human methylome. Nat Commun. 2016;7:11115.
   Google Scholar
• van Kempen PMW, Noorlag, R, Braunius, WW, et al. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics. 2014;9(2):194–203.
   Google Scholar
• Bailey P, Chang, DK, Nones, K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47–52.
   Google Scholar
• Wang Z, Wei P. IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration. Bioinformatics. 2021;36(22–23):5439–5447.
   Google Scholar
• Pedersen KS, Bamlet, WR, Oberg, AL, et al. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS ONE. 2011;6(3):e18223.
   Google Scholar
• Michaud DS, Ruan, M, Koestler, DC, et al. DNA methylation-derived immune cell profiles, CpG markers of inflammation, and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2020;29(8):1577–1585.
   Google Scholar
• Heiss JA, Brenner H. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Clin Epigenetics. 2017;9:24.
   Google Scholar
• van Veldhoven K, Polidoro, S, Baglietto, L, et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015;7:67.
   Google Scholar
• Battram T, Richmond, RC, Baglietto, L, et al. Appraising the causal relevance of DNA methylation for risk of lung cancer. Int J Epidemiol. 2019;48(5):1493–1504.
   Google Scholar
• Michaud DS, Ruan , M, Koestler, DC, et al. Epigenome-wide association study using prediagnostic bloods identifies new genomic regions associated with pancreatic cancer risk. JNCI Cancer Spectr. 2020;4(5): kaa041.
   Google Scholar
• Richard MA, Huan, T, Ligthart, S, et al. DNA methylation analysis identifies loci for blood pressure regulation. Am J Hum Genet. 2017;101(6):888–902.
   Google Scholar
• Mendelson MM, Marioni , RE, Joehanes, R, et al. Association of body mass index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease: a mendelian randomization approach. PLoS Med. 2017;14(1):e1002215.
   Google Scholar
• Hassan MM, Bondy , ML, Wolff, RA, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007;102(12):2696–2707.
   Google Scholar
• Li D, Morris, JS, Liu, J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009;301(24):2553–2562.
   Google Scholar
• Aryee MJ, Jaffe, AE, Corrada-Bravo, H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363–1369.
   Google Scholar
• Fortin JP, Labbe, A, Lemire, M, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15(12):503.
   Google Scholar
• Fortin JP, Triche TJ Jr., Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558–560.
   Google Scholar
• Chen YA, Lemire , M, Choufani, S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203–209.
   Google Scholar
• Maksimovic J, Phipson B, Oshlack A. A cross-package Bioconductor workflow for analysing methylation array data. F1000Res. 2016;5:1281.
   Google Scholar
• Leek JT, Parker, HS, Fertig, EJ, et al. sva: Surrogate variable analysis. R package; 2019. https://bioconductor.org/packages/release/bioc/html/sva.html.
   Google Scholar
• Ritchie ME, Phipson, B, Wu, D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   Google Scholar
• R Development Core Team. R: a language and environment for statistical computing. Vienna Austria: R Foundation for Statistical Computing; 2014.
   Google Scholar
• Jaffe AE, Murakam, P, Lee, H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41(1):200–209.
   Google Scholar
• Zemach A, McDaniel , IE, Silva, P, et al. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science. 2010;328(5980):916–919.
   Google Scholar
• Hansen KD. A manifest package for Illumina’s EPIC methylation arrays. R package; 2016. https://bitbucket.com/kasperdanielhansen/Illumina_EPIC.
   Google Scholar
• Hansen KD. IlluminaHumanMethylationEPICanno.ilm10b2.hg19: Annotation for Illumina’s EPIC methylation arrays. R package; 2016. https://bitbucket.com/kasperdanielhansen/Illumina_EPIC.
   Google Scholar
• Joehanes R, Johnson , AD, Barb, JJ, et al. Gene expression analysis of whole blood, peripheral blood mononuclear cells, and lymphoblastoid cell lines from the framingham heart study. Physiol Genomics. 2012;44(1):59–75.
   Google Scholar
• Lin H, Yin, X, Xie, Z, et al. Methylome-wide association study of atrial fibrillation in framingham heart study. Vol. 7. Scientific reports; 2017. p. 40377-40377.
   Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665.
   Google Scholar
• Gaunt TR, Butterworth , A, Thompson, SG, et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 2016;17:61.
   Google Scholar
• Greco MF, Minelli , C, Sheehan, NA, et al. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926–2940.
   Google Scholar
• VanderWeele TJ, Tchetgen, EJ, Cornelis, M, Kraft, P, et al. Methodological challenges in mendelian randomization. Epidemiology. 2014;25(3):427–435.
   Google Scholar
• Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. 1986. Int J Epidemiol. 2004;33(1):9.
   Google Scholar
• Burgess S, Labrecque JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates. Eur J Epidemiol. 2018;33(10):947–952.
   Google Scholar
• Tserel L, Kolde , R, Limbach, M, et al. Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes. Sci Rep. 2015;5:13107.
   Google Scholar
• Lee K, Kunkeaw , N, Jeon, SHH, et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. Rna. 2011;17(6):1076–1089.
   Google Scholar
• Lee YS. A novel type of non-coding RNA, nc886, implicated in tumor sensing and suppression. Genomics Inform. 2015;13(2):26–30.
   Google Scholar
• Kunkeaw N, Jeon, SH, Lee, K, et al. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 2013;32(32):3722–3731.
   Google Scholar
• Fort RS, Matho, C, Geraldo, MV, et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer. 2018;18(1):127.
   Google Scholar
• Ahn JH, Lee, HS, Lee, JS, et al. nc886 is induced by TGF-beta and suppresses the microRNA pathway in ovarian cancer. Nat Commun. 2018;9(1):1166.
   Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14(1):10–22.
   Google Scholar
• Hornung V, Ablasser , A, Charrel-Dennis, M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–518.
   Google Scholar
• Miller MW, Maniates, H, Wolf, EJ, et al. CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein. Vol. 67. Brain Behav Immun; 2018. p. 194–202.
   Google Scholar
• Ligthart S, Marzi , C, Aslibekyan, S, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.
   Google Scholar
• Sharma BR, Karki R, Kanneganti T-D. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol. 2019;49(11):1998–2011.
   Google Scholar
• Sollie S, Michaud , DS, Sarker, D, et al. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study. BMC Cancer. 2019;19(1):858.
   Google Scholar
• Szkandera J, Stotz , M, Absenger, G, et al. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014;110(1):183–188.
   Google Scholar
• Purow B. Molecular pathways: Targeting diacylglycerol kinase alpha in cancer. Clin Cancer Res. 2015;21(22):5008–5012.
   Google Scholar
• Weigel C, Veldwijk , M, Oakes, C, et al. Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis. Nat Commun. 2016;7:10893.
   Google Scholar
• Jia M, Han, J, Hang, D, et al. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women. Tumour Biol. 2016;37(6):8019–8025.
   Google Scholar
• Zhang Q, Yin, J, Zhang, Y, et al. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 2013;87(22):12176–12186.
   Google Scholar
• Lan Q, Hsiung , CA, Matsuo, K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012;44(12):1330–1335.
   Google Scholar
• Michailidou K, Lindstrom , S, Dennis, J, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92–94.
   Google Scholar
• Shiraishi K, Okada , Y, Takahashi, A, et al. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nat Commun. 2016;7:12451.
   Google Scholar